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The high reinduction rate may result
from (1) avoidance of drug resistance, (2)
early diagnosis ofrelapse or (3) positive effect
of immunotherapy or a combination of these
factors.
IMMUNE COMPETENCE IN COLON
CANCER: RELATIONSHIP OF PRE-
TREATMENT TESTS TO DIAGNOSIS
AND TUMOUR STAGE. A. M. MANDER,
P. M. BOLTON, R. H. WHITEHEAD, R. G.
NEWCOMBE and L. E. HUGHES, Department
of Surgery, Welsh National School of Medi-
cine, Cardiff.
A spectrum of immunological tests was
performed to assess cellular and humoral
immunity in 40 patients with colon cancer.
Controls had suspected cancer but proved to
have benign disease.
The tests employed were measurements of
peripheralwhitecellcount, lymphocyte count,
serum immunoglobulin levels, lymphocyte
response to PHA, DNCB response, and the
Montoux test. Results were correlated with
diagnosis and tumour stage. The colon
cancer patients had both absolute and
relative lymphocytopaenia. Serum IgM and
IgA levels were significantly raised in the
cancer group and were highest in the patients
with distant spread. No difference in
lymphocyte response to PHA was observed.
DNCB and Mantoux responses were markedly
depressed in the cancer group even in patients
with early cancer. Discrimination between
benign and malignant conditions was not
greatly improved by using the tests in
combination.
HOST TUMOUR RELATIONSHIP IN
STOMACH CANCER-CORRELATION
OF HISTOLOGICAL CRITERIA WITH
TESTS OF IMMUNE COMPETENCE.
A. M. MANDER, C. A. MORGAN, E. W. OWEN,
J. ZLOSNICK and L. E. HUGHES, Welsh
National School of Medicine, Cardiff.
The current prospective study involves
multifactorial computer analysis of 50
stomach cancer patients who have been
assessed from two separate approaches: the
first by preoperative estimation of host
immune competence, measuring lymphocyte
response to phytohaemagglutinin, peripheral
lymphocyte count, serum immunoglobulin
levels, Mantoux response and dinitrochloro-
benzene skin testing, and the second approach
by histological examination of tumour and
lymph nodes for evidence of cellular and
humoral immune response.
Correlation of the two sets of data with
each other and with clinical tumour staging
has given a broad view of host tumour
interaction in stomach cancer. The results
will allow an assessment of whether histo-
logical parameters of cellular and humoral
immunity correlate with results obtained by
immunosurveillance tests, and which ofthese
is most relevant to the clinical outcome ofthe
disease.
HUMORAL IMMUNITY IN HUMAN
LUNG NEOPLASIA. M. DAWSON and
M. MOORE, Paterson Laboratories, Man-
chester.
Sera from patients with carcinoma of the
lung were examined for evidence of humoral
immunity towards allogeneic lung carcinoma
cells in short-term culture.
Microcytotoxicity assays were used to
investigate: (a) complement dependent cyto-
toxicity; (b) serum mediated cellular cyto-
toxicity and (c) " blocking" activity of sera
towards leucocytes obtained from patients
with lung carcinoma.
The incidence of complement dependent
cytotoxic antibody to the sera was low, only
3/18 (17%) sera giving positive reactions. A
higher proportion 8/18 (44%) of the same
sera were found toiinduce cellularcytotoxicity
against lung carcinoma cells in leucocytes
obtained from healthy donors, while " block-
ing" activity towards lung cancer patients'
leucocytes was found in 10/18 (56%) sera.
The latter phenomenon was not specific since
5/7 (71%) sera from patients with unrelated
cancers also reduced the cytotoxicity of
leucocytes from lung cancer patients for
cultured lung carcinoma cells. The impli-
cations ofthese findings for the interpretation
of in vitro cytotoxicity tests in the human
allogeneic context are to be examined.
MACROPHAGE MIGRATION INHIBI-
TION AND IMMUNOGLOBULIN PRO-
DUCTION BY HODGKIN'S DISEASE
(HD) BIOPSY SPECIMENS IN VITRO.
D. B. JONES, S. V. PAYNE, J. L. SMITH, and
D. H. WRIGHT, Department of Experimental
Pathology, Southampton University.244 B.A.C.R. 16TH ANNUAL GENERAL MEETING
Recent theories of the aetiology of HD
have postulated immune reactivity to viral or
thymic antigens as fundamental to the
disease process (Kaplan, Hodqkin's Disease,
Harvard University Press, 1972).
HD spleen tissue in short-term culture
produces high levels of immunoglobulin G in
comparison with control spleen cultures.
Preliminary results suggest that this immuno-
globulin binds to peripheral blood lympho-
cytes. In addition, supernatants from HD
lymph node and spleen cultures inhibited the
migration of guinea-pig peritoneal macro-
phages in vitro in 11 of 15 cases. Control
supernatants from carcinomatosis and re-
active lymph nodes and normal spleens
inhibited significantly in only 1 of 16 cases.
The biological properties of this inhibitor
parallel those described for lymphocyte
derived Migration Inhibition Factor: MIF
(David and David, 1972). Lymphokine
production in vitro is compatible with
elevated levels of immune reactivity in HD
tissue.
ATTEMPTS TO CULTURE HUMAN
TUMOURS IN VITRO. R. H. WHITEHEAD
and L. E. HUGHES, Department of Surgery,
Welsh National School ofMedicine, Cardiff.
There is a need for tissue culture lines of
human tumours for in vitro studies.
Attempts have been made to establish such
lines from 220 tumour specimens. Ninety-
six specimens from breast carcinoma patients
have been cultured. These comprised 64
tumour specimens and 32 pleural effusions
from patients with advanced disease. No
cell lines have been obtained from the
tumour specimens although epithelial cells
proliferated for at least one month in 19 ofthe
64; 24/32 pleural effusions proliferated and 13
of these yielded cell lines. The nature of the
cell is in doubt because mesothelial cells grow
very well under the culture conditions used.
Seven of 29 colonic carcinomata speci-
mens and 7/8 ascitic fluids from patients
with colon carcinoma have also grown for at
least one month. Three cell lines have been
obtained from ascitic fluids; however, the
cells are considered to be mainly mesothelial
inorigin. Goodgrowth has been obtained from
12/24 melanomata cultured and two cell lines
have been established.
Although numerous supplements have
been added to the basic McCoy's 5A medium,
enhanced growth was obtained only after the
addition of insulin and galactose.
PROTECTION AGAINST THE CYTO-
TOXIC AZIRIDINE CB1954 BY AN
ARYLIMIDAZOLE WITH ANTI-
INFLAMMATORY ACTIVITY. J. A.
HICKMAN and D. H. MELZACK, ChesterBeatty
Research Institute London.
CB1954 (5-[1-aziridinyl]-2, 4-dinitroben-
zamide) is a potent and selective cytotoxic
compound for the Walker tumour (Cobb et al.,
Biochem. Pharmac., 1969, 18, 151]9). The
cytotoxicity was protected against by purine
nucleotides and the purine precursor AIC
(4-amino-5-imidazolecarboxamide) (Connors
and Melzack, Int. J. Cancer, 1971, 7, 86) but
CB1954 had no effect on de novo purine
biosynthesis (Mandel et al., Cancer Res., 1974,
34, 275). In the search for the mechanism of
action ofCB1954 this protection phenomenon
has been studied further and the anti-
inflammatory agent 2-phenyl AIC (Heyes and
Ward, Br. Appl.,41, 261/70)hasbeenfoundto
be a potent protector which gives a dose
reduction factor of 90 in an anti-tumour test
of CB1954.
2-Phenyl-AIC inhibits prostaglandin
synthesis, as do a number of non-steroidal
anti-inflammatory agents such as indome-
thacin. However, since such agents gave no
protection against CB1954, it is considered
unlikely that the protection mechanism
involves prostaglandin synthesis.
LEUCOCYTOTOXICITY IN MALIG-
NANT AND) NON-MALIGNANT COL-
ONIC DISEASES. B. M. VOSE, M. MOORE,
P. F. SCHOFIELD and I. W. DYMOCK, Paterson
Laboratories, Manchester, Park Hospital and
University of South Manchester.
The cytotoxicity of peripheral blood
leucocyte3 from healthy donors and from
patients with disorders of the large bowel,
including ulcerative colitis, colon carcinoma,
Crohn's disease, irritable colon and diverti-
cular disease for cells cultured from malig-
nant, normal adult and foetal colonic tissues
has been compared. Leucocytotoxicity was
defined in this study as a statistically signi-
ficant reduction of target cell survival in
microplate wells treated with leucocyte
preparations compared with the survival of
cells in wells exposed to growth medium